Hideo Yuki
Papers
1
Total Citations
12
H-Index
1
About
Dr. Hideo Yuki is a distinguished urologic oncologist whose research focuses on refining surgical decision-making and prognostic accuracy in prostate cancer management. His work centers on the integration of advanced biomarkers and detailed histopathological data to improve outcomes for patients undergoing robot-assisted radical prostatectomy. Dr. Yuki’s most cited study, “Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy” (2017, 12 citations), provides critical insights into how prostate-specific antigen (PSA) density and biopsy core characteristics can guide surgeons in determining the need for extended resection or lymph node dissection. This contribution helps bridge the gap between preoperative risk stratification and intraoperative decision-making, offering a more personalized approach to high-risk cases. While his citation count reflects a focused, emerging impact, Dr. Yuki’s work is notable for its practical relevance, directly influencing clinical protocols in robotic surgery. His research underscores a commitment to evidence-based urology, making him a valuable voice in the ongoing effort to optimize oncological outcomes through precise, data-driven surgical planning.
Research Focus
Key Achievements
Top Papers
- 1